The tubulin colchicine domain: a molecular modeling perspective
- PMID: 21990124
- DOI: 10.1002/cmdc.201100361
The tubulin colchicine domain: a molecular modeling perspective
Abstract
Computational approaches have been increasingly applied to drug design over the past three decades and have already provided some useful results in the discovery of anticancer drugs. Given the increased availability of crystal structures in recent years, a growing number of molecular modeling studies on tubulin have been reported. Herein we present a brief overview of the role played by computational methods in anti-tubulin research, specifically in the context of colchicine binding agent research. An overview of current structures is reported, along with a brief discussion on the issues associated with the various tubulin isotypes. Finally, a summary of the most recent and relevant results is presented, highlighting the challenges and opportunities faced by researchers in this field.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Discovery of small molecule inhibitors that interact with γ-tubulin.Chem Biol Drug Des. 2012 May;79(5):639-52. doi: 10.1111/j.1747-0285.2012.01340.x. Epub 2012 Feb 15. Chem Biol Drug Des. 2012. PMID: 22268380
-
Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.Med Res Rev. 2008 Jan;28(1):155-83. doi: 10.1002/med.20097. Med Res Rev. 2008. PMID: 17464966 Review.
-
Computational design and biological testing of highly cytotoxic colchicine ring A modifications.Chem Biol Drug Des. 2010 Jun;75(6):541-50. doi: 10.1111/j.1747-0285.2010.00970.x. Epub 2010 Apr 8. Chem Biol Drug Des. 2010. PMID: 20408852
-
Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery.FEBS J. 2016 Jan;283(1):102-11. doi: 10.1111/febs.13555. Epub 2015 Nov 4. FEBS J. 2016. PMID: 26462166
-
Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective.Drug Discov Today. 2022 Mar;27(3):759-776. doi: 10.1016/j.drudis.2021.12.001. Epub 2021 Dec 8. Drug Discov Today. 2022. PMID: 34890803 Free PMC article. Review.
Cited by
-
How to deal with low-resolution target structures: using SAR, ensemble docking, hydropathic analysis, and 3D-QSAR to definitively map the αβ-tubulin colchicine site.J Med Chem. 2013 Sep 26;56(18):7382-95. doi: 10.1021/jm400954h. Epub 2013 Sep 9. J Med Chem. 2013. PMID: 23961916 Free PMC article.
-
Tubulin-interactive stilbene derivatives as anticancer agents.Cell Mol Biol Lett. 2013 Sep;18(3):368-97. doi: 10.2478/s11658-013-0094-z. Epub 2013 Jul 1. Cell Mol Biol Lett. 2013. PMID: 23818224 Free PMC article. Review.
-
Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents.Medchemcomm. 2017 Jul 4;8(8):1592-1603. doi: 10.1039/c7md00227k. eCollection 2017 Aug 1. Medchemcomm. 2017. PMID: 30108870 Free PMC article. Review.
-
Antileishmanial activity and tubulin polymerization inhibition of podophyllotoxin derivatives on Leishmania infantum.Int J Parasitol Drugs Drug Resist. 2017 Dec;7(3):272-285. doi: 10.1016/j.ijpddr.2017.06.003. Epub 2017 Jun 28. Int J Parasitol Drugs Drug Resist. 2017. PMID: 28719882 Free PMC article.
-
Potent and Selective Benzothiazole-Based Antimitotics with Improved Water Solubility: Design, Synthesis, and Evaluation as Novel Anticancer Agents.Pharmaceutics. 2023 Jun 9;15(6):1698. doi: 10.3390/pharmaceutics15061698. Pharmaceutics. 2023. PMID: 37376146 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
